All lobbying filings

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) filed a Q2 report for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) on July 21, 2025.

Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

All filings by THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) · Everything THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 20, 2025.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$1,890,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

KARA SMITH New on this filing

Previously held: Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Medicare/Medicaid

P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; Issues related to transparency and prior authorization.

Health Issues

S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues related to P.L.119-21 (H.R. 1), the One Big Beautiful Bill Act, and budget reconciliation; Issues related to H.R. 2041, the Hidden Fee Disclosure Act of 2025.

Defense

Pharmacy issues related to the National Defense Authorization Act, FY2026.

Pharmacy

S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act; Issues related to the specialty drug market.

Labor Issues/Antitrust/Workplace

Issues related to competition in the health care marketplace.

Bills named in this filing 13

H.R. 4189
To direct the Secretary of the Navy to recognize certain aspects of the National Navy UDT-SEAL Museum in Fort Pierce, F…
S. 2016
Chugach Alaska Land Exchange Oil Spill Recovery Act of 2025
S. 864
HELP Copays Act
H.R. 247
Health Care Affordability Act of 2025
H.R. 1
One Big Beautiful Bill Act
H.R. 2041
Hidden Fee Disclosure Act of 2025
S. 1542
DRUG Act
H.R. 2214
DRUG Act
H.R. 5378
Lower Costs, More Transparency Act
S. 1339
Pharmacy Benefit Manager Reform Act
S. 526
Pharmacy Benefit Manager Transparency Act of 2025
S. 1040
Drug Competition Enhancement Act
S. 1041
Affordable Prescriptions for Patients Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.